Perspectives On The Pharmaceutical Industry-Reference-Cited by-同舟云学术

Perspectives On The Pharmaceutical Industry

Published:2001-09 Issue:5 Volume:20 Page:136-149
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Reinhardt Uwe E.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference9 articles.

1. S. Heffler et al. “Health Spending Growth Up in 1999: Faster Growth Expected in the Future,”Health Affairs(Mar/Apr 2001 ): 193 –203.

2. R.W. Dubois et al. “Explaining Drug Spending Trends: Does Perception Match Reality?”Health Affairs(Mar/Apr 2000 ): 231 –239.

3. M.L. Berk and A.C. Monheit, “The Concentration of Health Care Expenditures, Revisited,”Health Affairs(Mar/Apr 2001 ): 9 –18.

4. See Verband Forschender Arzneimittelhersteller e.V.Statistics 2000: Die Arzneimittel in Deutschland(Annual Report of the Association of Research-Based Pharmaceutical Producers, 2000 ), 26 .

5. For an analysis of this subject, see F.M. Scherer , “The Link between Gross Profits and Pharmaceutical R&D Spending,”Health Affairs(Sep/Oct 2001 ): 216 –220.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using machine learning to comprehend and forecast Post-COVID-19 pharmaceutical sales;2023 Advanced Computing and Communication Technologies for High Performance Applications (ACCTHPA);2023-01-20

2. The Single Market in Pharmaceuticals;Review of Industrial Organization;2019-02-20

3. Healthy or Sick?;CAMB ST COMP PUB POL;2018-07-27

4. The opportunity cost of pharmaceutical price increases: improving health by investing in education;Critical Public Health;2018-03-06

5. U.S. Airlines and Antitrust: The Struggle for Defensible Policy Towards a Unique Industry;Indiana Law Review;2017-03-10